Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 5Prostatic Neoplasms 3Desmoid Tumors 3Melanoma 2Lung Neoplasms 2Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Solid Tumor, Adult 1Skin Neoplasms 1Sarcoma 1Pancreatic Adenocarcinoma Locally Advanced 1Neuroma 1Neuralgia 1Neoplasm Metastasis 1Liver Neoplasms 1Liver Metastasis 1Hypesthesia 1Disease 1Colorectal Neoplasms 1Cirrhosis, Familial, with Pulmonary Hypertension 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Agnosia 1Adenocarcinoma of Lung 1

Interventions

sintilimab 1lenvatinib 1Cryosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Liver Metastasis × Cryosurgery × Clear all
NCT05098847 2025-02-27

Cryoablation Combined with Sintilimab Plus Lenvatinib in Previously Treated Unresectable Liver Metastasis from Solid Tumors

Fudan University

Phase 2 Recruiting
25 enrolled

Liver Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡